AIMS: To evaluate the toxicity and cellular uptake of both undifferentiated and differentiated human adipose-derived stem cells (hASCs) exposed to silver nanoparticles (Ag-NPs), and to assess their effect on hASC differentiation. MATERIALS & METHODS: hASC were exposed to 10- or 20-nm Ag-NPs at concentrations of 0.1, 1.0, 10.0, 50.0 and 100.0 µg/ml either before or after differentiation down the adipogenic or osteogenic pathways. RESULTS: Exposure of hASC to either 10- or 20-nm Ag-NPs resulted in no significant cytotoxicity to hASC, and minimal dose-dependent toxicity to adipogenic and osteogenic cells at 10 µg/ml. Each of the hASC, adipogenic and osteogenic cells showed cellular uptake of both 10- and 20-nm Ag-NPs, without causing significant ultrastructural alterations. Exposure to 10- or 20-nm Ag-NPs did not influence the differentiation of the cells, and at antimicrobial concentrations of Ag-NPs resulted in a minimal decrease in viability. CONCLUSION: The biocompatibility of Ag-NPs with both undifferentiated and differentiated hASC establishes their suitability for incorporation into tissue-engineered graft scaffolds, for the prevention of bacterial contamination upon implantation.
AIMS: To evaluate the toxicity and cellular uptake of both undifferentiated and differentiated human adipose-derived stem cells (hASCs) exposed to silver nanoparticles (Ag-NPs), and to assess their effect on hASC differentiation. MATERIALS & METHODS:hASC were exposed to 10- or 20-nm Ag-NPs at concentrations of 0.1, 1.0, 10.0, 50.0 and 100.0 µg/ml either before or after differentiation down the adipogenic or osteogenic pathways. RESULTS: Exposure of hASC to either 10- or 20-nm Ag-NPs resulted in no significant cytotoxicity to hASC, and minimal dose-dependent toxicity to adipogenic and osteogenic cells at 10 µg/ml. Each of the hASC, adipogenic and osteogenic cells showed cellular uptake of both 10- and 20-nm Ag-NPs, without causing significant ultrastructural alterations. Exposure to 10- or 20-nm Ag-NPs did not influence the differentiation of the cells, and at antimicrobial concentrations of Ag-NPs resulted in a minimal decrease in viability. CONCLUSION: The biocompatibility of Ag-NPs with both undifferentiated and differentiated hASC establishes their suitability for incorporation into tissue-engineered graft scaffolds, for the prevention of bacterial contamination upon implantation.
Authors: Jose Ruben Morones; Jose Luis Elechiguerra; Alejandra Camacho; Katherine Holt; Juan B Kouri; Jose Tapia Ramírez; Miguel Jose Yacaman Journal: Nanotechnology Date: 2005-08-26 Impact factor: 3.874
Authors: Patricia A Zuk; Min Zhu; Peter Ashjian; Daniel A De Ugarte; Jerry I Huang; Hiroshi Mizuno; Zeni C Alfonso; John K Fraser; Prosper Benhaim; Marc H Hedrick Journal: Mol Biol Cell Date: 2002-12 Impact factor: 4.138
Authors: S D McCullen; Y Zhu; S H Bernacki; R J Narayan; B Pourdeyhimi; R E Gorga; E G Loboa Journal: Biomed Mater Date: 2009-04-24 Impact factor: 3.715
Authors: Maqusood Ahamed; Michael Karns; Michael Goodson; John Rowe; Saber M Hussain; John J Schlager; Yiling Hong Journal: Toxicol Appl Pharmacol Date: 2008-09-27 Impact factor: 4.219
Authors: Tik Shing Cheung; Pui Man Lau; Haifei Lu; Ho Pui Ho; Pauline Po Yee Lui; Siu Kai Kong Journal: Toxicol Res (Camb) Date: 2015-11-23 Impact factor: 3.524
Authors: Mahsa Mohiti-Asli; Casey Molina; Thamonwan Diteepeng; Behnam Pourdeyhimi; Elizabeth G Loboa Journal: Tissue Eng Part A Date: 2016-10-25 Impact factor: 3.845
Authors: Anda R Gliga; Sara Skoglund; Inger Odnevall Wallinder; Bengt Fadeel; Hanna L Karlsson Journal: Part Fibre Toxicol Date: 2014-02-17 Impact factor: 9.400